CONMED Corporation (NYSE: CNMD) AI-Powered Stock Analysis
See how CONMED Corporation scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
CNMD●NYSE
HealthcareMedical - Devices
$49.82
$0.34(0.69%)
U.S. Market opens in 3h 1m
CONMED Corporation (NYSE: CNMD) AI-Powered Stock Analysis
See how CONMED Corporation scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerCONMED Corporation (NYSE: CNMD) Stock Overall Grade
CONMED Corporation's grade for its NYSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to CONMED Corporation's overall NYSE stock rating.
Forecast
BScore
67/100Financial Growth
A+Score
95/100Fundamental Growth
BScore
69/100Key Ratios
B+Score
77/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
CScore
42/100CONMED Corporation (NYSE: CNMD) AI-Powered Stock Analysis
On the NYSE, CNMD demonstrates Good performance with an overall Forecast Score of 67/100 (B), reflecting high confidence in its potential. Financial Growth (95/100, A+) and Fundamental Growth (69/100, B) highlight its stability, while Key Ratios (77/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NYSE-listed stock shows competitive strength. Analyst Consensus (42/100, C) suggests High divergence in outlook.(NYSE: CNMD) Component Analysis Explained
Understand the key factors behind each CONMED Corporation (NYSE: CNMD) stock grade, including financials, comparisons, and forecasts.